肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

MLL易位、组蛋白修饰与白血病干细胞发育

MLL translocations, histone modifications and leukaemia stem-cell development

原文发布日期:2007-11-01

DOI: 10.1038/nrc2253

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

MLL易位、组蛋白修饰与白血病干细胞发育

MLL translocations, histone modifications and leukaemia stem-cell development

原文发布日期:2007-11-01

DOI: 10.1038/nrc2253

类型: Review Article

开放获取: 否

 

要点:

  1. Mixed lineage leukaemia (MLL) translocations define a unique group of leukaemias, which phenotypically can be defined as acute myeloid leukaemias (AML), acute lymphoblastic leukaemias (ALL) or biphenotypic (mixed lineage) leukaemias (MLL).
  2. MLL is a methyltransferase that is involved in the positive regulation of Hox gene expression and methylation of histone H3 lysine residue 4 (H3K4).
  3. As a result of inter-chromosomal translocations, the N terminus of MLL can be 'fused' to the C terminus of over 50 different partners, which results in the loss of the H3K4 methyl transferase domain.
  4. A major group of MLL fusion partners appear to interact with the DOT1L methyltransferase that positively regulates transcription by methylation of histone H3 lysine residue 79 (H3K79).
  5. MLL fusion proteins efficiently transform haematopoietic precursors to leukaemia stem cells.

 

要点翻译:

  1. 混合谱系白血病(MLL)易位界定了一组独特的白血病类型,在表型上可表现为急性髓系白血病(AML)、急性淋巴细胞白血病(ALL)或双表型(混合谱系)白血病(MLL)。
  2. MLL是一种甲基转移酶,参与Hox基因表达的正向调控以及组蛋白H3赖氨酸残基4(H3K4)的甲基化过程。
  3. 由于染色体间易位,MLL的N端可与超过50种不同伙伴蛋白的C端发生"融合",导致H3K4甲基转移酶结构域缺失。
  4. 大部分MLL融合伴侣蛋白会与DOT1L甲基转移酶相互作用,后者通过催化组蛋白H3赖氨酸残基79(H3K79)甲基化正向调控转录。
  5. MLL融合蛋白能高效地将造血前体细胞转化为白血病干细胞。

 

英文摘要:

Translocations that involve the mixed lineage leukaemia (MLL) gene identify a unique group of acute leukaemias, and often predict a poor prognosis. The MLL gene encodes a DNA-binding protein that methylates histone H3 lysine 4 (H3K4), and positively regulates gene expression including multiple Hox genes. Leukaemogenic MLL translocations encode MLL fusion proteins that have lost H3K4 methyltransferase activity. A key feature of MLL fusion proteins is their ability to efficiently transform haematopoietic cells into leukaemia stem cells. The link between a chromatin modulator and leukaemia stem cells provides support for epigenetic landscapes as an important part of leukaemia and normal stem-cell development.

摘要翻译: 

涉及混合谱系白血病(MLL)基因的易位可识别出一类独特的急性白血病,且往往预示预后不良。MLL基因编码一种能与DNA结合的蛋白,该蛋白可使组蛋白H3第4位赖氨酸(H3K4)发生甲基化,从而正向调控包括多个Hox基因在内的基因表达。致病的MLL易位会产生MLL融合蛋白,这些蛋白丧失了H3K4甲基转移酶活性。MLL融合蛋白的一个关键特征是其能够高效地将造血细胞转化为白血病干细胞。染色质调节因子与白血病干细胞之间的联系支持了表观遗传景观是白血病及正常干细胞发育的重要组成部分。

原文链接:

MLL translocations, histone modifications and leukaemia stem-cell development

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……